Taking ginsenoside CK as an example, we use AI technology and biomimetic concepts to simulate the transformation process of ginsenosides in the human body and accurately screen the best biological enzyme from nearly 2 million enzymes.

Covers cutting-edge formulation technologies such as nano-encapsulation and targeted delivery. Taking the star ingredient AuroGlab as an example, it applies the original 28-nanometer encapsulation technology to solve the pain points of easy inactivation and low transdermal penetration of traditional licorice formulations; and integrates the targeted delivery system to accurately guide the active ingredients to act on deep targets in the skin, achieving a breakthrough improvement in brightening and spot-removing effects.

Covering intelligent responsive materials and biocompatible design technologies, we are committed to developing efficient and controllable drug delivery and tissue repair solutions. Taking the innovative thermosensitive hydrogel as an example, we precisely design poloxamer-based materials to achieve intelligent gelation at body temperature, perfectly encapsulating and protecting the active ingredient ginsenoside CK.

By leveraging its dynamic programmability—using intermolecular forces such as hydrogen bonding and hydrophobic interactions—supramolecular structures with pH/enzyme/light-responsive properties can be constructed. For example, β-cyclodextrin encapsulates the styrene groups of pterostilbene through hydrophobic interactions within its cavity. Simultaneously, the hydroxyl groups on the cyclodextrin edge (hydrogen bond donors) form an intermolecular hydrogen bond network with the methoxy oxygen atoms of pterostilbene (hydrogen bond acceptors), creating a stable supramolecular encapsulation complex.